Drug Database
Back to search

Poland· PL-100082325

Maalox

A kombinationen von aluminium-, calcium- und magnesiumsalzen product containing aluminii hydroxidum + magnesii hydroxidum, registered in Poland by Opella Healthcare Poland Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC A02AD01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMaaloxATCA02AD01REGISTER NO.PL-100082325PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aluminii hydroxidum + magnesii hydroxidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Kombinationen von aluminium-, calcium- und magnesiumsalzen is registered in 10 of 19 countries.

Countries holding a registration under ATC A02AD01 (kombinationen von aluminium-, calcium- und magnesiumsalzen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search kombinationen von aluminium-, calcium- und magnesiumsalzen products by name

Kombinationen von aluminium-, calcium- und magnesiumsalzen · ATC A02AD01

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Aluminii hydroxidum + Magnesii hydroxidum
Manufacturer
Opella Healthcare Poland Sp. z o.o.
Country
Poland (PL)
ATC code
A02AD01
ATC class
Kombinationen von Aluminium-, Calcium- und Magnesiumsalzen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990225217
  • gtin
    05909990225224

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

16 interactions on record for kombinationen von aluminium-, calcium- und magnesiumsalzen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check kombinationen von aluminium-, calcium- und magnesiumsalzen against other medicinesHow interaction checks work

Kombinationen von aluminium-, calcium- und magnesiumsalzen · interactions on record

16 records

16 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Kombinationen von aluminium-, calcium- und magnesiumsalzen in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All kombinationen von aluminium-, calcium- und magnesiumsalzen products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Bulgaria · Алмагел
  • Cyprus · Maalox
  • Czechia · Maalox
  • Germany · Maaloxan
  • Estonia · Maalox, Maalox (Suhkruvabad)
  • France · Maalox Maux D’estomac, Maalox Maux D’estomac Fruits Rouges
  • United Kingdom (Northern Ireland) · Maalox
  • Greece · Aludrox, Maalox
  • Ireland · Maalox
  • Italy · Maalox, Maalox Aroma Menta
  • Lithuania · Maalox, Maalox (Be Cukraus)
  • Latvia · Maalox, Maalox (Nesatur Cukuru)
  • Netherlands · Aluminium Oxide/Magnesium Hydroxide Aurobindo, Antagel
  • Norway · Novaluzid
  • Romania · Dicarbocalm Aromă De Lămâie, Dicarbocalm Cu Aromă De Coacăze Negre
  • Slovakia · Maalox, Maalox Bez Cukru S Príchuťou Citróna

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/22e00f0c-4cea-4657-9cb2-fd3c20ec7873
GET /v1/drugs/22e00f0c-4cea-4657-9cb2-fd3c20ec7873?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "400 mg + 400 mg",
  "packaging": "05909990225217 ¦ OTC ¦ 12382\n20 tabl.\n05909990225224 ¦ OTC ¦ 12383\n40 tabl.",
  "substance": "Aluminii hydroxidum 400 mg + Magnesii hydricum 400 mg",
  "common_name": "Aluminii hydroxidum + Magnesii hydroxidum",
  "pl_product_id": "100082325",
  "pozwolenie_nr": "02252",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about kombinationen von aluminium-, calcium- und magnesiumsalzen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console